Baku 4° C
COVID vaccine manufacturers to make billions from selling third dose
Business
- 26 September, 2021
- 07:43
Pfizer may receive $26 billion from the sales of the third dose of its coronavirus vaccine in 2022, Report informs with reference to the Morningstar financial company.
The company's sales forecast for this year is $4 billion.
Another vaccine maker, Moderna, might earn $2 billion this year and $14 billion next year.
At the same time, Morningstar analysts believe that sales might increase significantly next year as countries approve the third dose.
Author
Latest News
20:53
Commander of Internal Troops to be appointed by President of Azerbaijan
Domestic policy20:31
Kobakhidze: USAID funded projects contrary to Georgia's interests
Region20:06
Serbia's NIS, Hungary's MOL ask US to suspend sanctions
Other countries19:57
Israel says it has killed senior IRGC commander in Lebanon
Other countries19:43
Budget of Mandatory Health Insurance Fund for 2025 revised
Domestic policy19:25
President of Azerbaijan approves law on internal troops
Domestic policy19:00
President Ilham Aliyev ratifies 'State Program on Improvement of Official Statistics in the Republic of Azerbaijan for 2026–2030'
Domestic policy18:56
Nearly half a billion passengers transported by public transport in Azerbaijan this year
Infrastructure18:35
Video